FDA inspection
Dana Diabecare USA LLC: FDA inspection ending Feb 27, 2004
FDA inspection 315771 · Official Action Indicated (OAI) · New Orleans, LA
Key facts
| Inspection ID | 315771 |
|---|---|
| Firm | Dana Diabecare USA LLC |
| FEI number | 3003432903 |
| Address | 541 Julia Street, 3rd Floor |
| City | New Orleans |
| State | LA |
| ZIP | 70130-3690 |
| Fiscal year | 2004 |
| Inspection end date | Feb 27, 2004 |
| Classification | Official Action Indicated (OAI) |
| Project area | Compliance: Med Devices |
| Product type | Devices |
| Warning letter | UCM146522 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data